Search

Author/Creator Morikawa, N

1. 1490PA prospective observational study of HER2 alterations in NSCLCs: HOT1303-A. (23rd October 2018)

Authors:
Goda1, T; Kinoshita, I; Oizumi, S; Nakano2, K; Harada, T; Kawai, Y; Sakakibara-Konishi5, J; Yokouchi, H; Morikawa, N; Yamada, N; Yamazaki, S; Sugawara, S; Asahina, H; Amano, T; Hatanaka, Y; Matsuno, Y; Nishihara, H; Isobe, H; Nishimura, M; Dosaka-Akita, H
Journal:
Annals of oncology
Issue:
Volume 29(2018)Supplement 8
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. 521PA randomized, phase II study comparing irinotecan versus amrubicin as maintenance therapy after first-line induction therapy for extensive disease small cell lung cancer (HOT1401/NJLCG1401). (24th November 2019)

Authors:
Baba, K; Tanaka, H; Fujita, Y; Nakamura, A; Kikuchi, E; Kawai, Y; Harada, T; Watanabe, N; Yokouchi, H; Usui, K; Saito, R; Watanabe, H; Masuda, T; Fukuhara, T; Kudo, K; Honda, R; Oizimi, S; Maemondo, M; Inoue, A; Morikawa, N
Journal:
Annals of oncology
Issue:
Volume 30(2019)Supplement 9
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗